Neural networks are emblematic of complex systems, so it's no surprise that the field of neurology is eclectic and intricate, too. Main challenges for neurologists are therapies of and research on stroke, seizures, movement disorders such as Parkinson's disease, autoimmune disorders such as multiple sclerosis and dementias such as Alzheimer's disease.
Movement disorders often show overlapping symptoms, making it difficult for doctors to make the correct diagnosis. A new AI tool could help distinguish between different disorders, such as tremor and myoclonus.
As Emergency Departments (EDs) get ever busier, focus has fallen on the role artificial Intelligence (AI) can play in supporting patients and clinicians in delivering urgent care. The topic took centre stage in a session looking at the ethics of AI in the ED at the annual congress of the European Society of Emergency Medicine (EUSEM) in Copenhagen.
Researchers evaluated the clinical value of using ChatGPT to interpret seizure semiology in order to predict which brain areas to remove to achieve seizure freedom in epilepsy patients.
Researchers from Université Laval discovered that the retina of people with Parkinson's disease responds differently to light than that of healthy people. This offers new diagnostic options.
Bringing diagnostics and therapy closer together - that is the basic concept behind theranostics. Through further development of its PET/MR scanners, Siemens Healthineers aims to advance this approach. Andreas Schneck, Head of the MRI Division at Siemens Healthineers, talks about the new system, which was also presented at the European Congress of Radiology (ECR) in Vienna, and its advantages in…
Using an advanced PET scanner, US radiologists explore how cancer, neurodegenerative diseases and other systemic conditions, can affect the brain by assessing the impact on the blood-brain barrier.
Using vibrations to help people living with Parkinson's disease regain motor control: Engineering students have created a special glove that aims to reduce the symptoms of the condition.
A new study found that a significant proportion of Parkinson's disease diagnoses are later corrected. The results demonstrate the need for improved diagnostic processes.
A new AI tool can extract key information from brain MRI scans of multiple sclerosis (MS) patients. This could be used to improve disease and treatment response monitoring.
RNA researcher Anastasia Khvorova, PhD, professor of RNA therapeutics at UMass Chan Medical School, will receive this year's Else Kröner Fresenius Prize for Medical Research on May 15, 2025. The award ceremony will be a part of the festive event together with the Fresenius SE & Co. KGaA celebrating the 100th birthday of Else Kröner, at the Städel Museum in Frankfurt am Main.
Using the COX-2 enzyme, a new PET imaging approach offers a never-before-seen view of inflammation in the brain, opening the door for clinical and research settings for various brain disorders.
Using ‘parallel transmit’ technique, researchers have found a new way to detect lesions in the brain of patients with treatment-resistant epilepsy in an MRI scan, without imaging signal dropouts.
As of May 1st, Maartje Huijbers holds the position of vice dean of research, a new position within the Leiden University Medical Center (LUMC). Huijbers is associate professor and research group leader in the Department of Human Genetics and the Department of Neurology. She will combine her work as a scientist with the position of vice dean.
Electrodes implanted directly onto the brain’s visual cortex could eventually restore a rudimentary form of vision to people suffering from blindness worldwide, new research suggests.
Chronic pain is more common among women, but why is that? New research explores sex-specific differences in pain signal communication in the nervous system to help answer this question.
A new system that seamlessly integrates an implanted spinal cord neuroprosthesis with rehabilitation robotics delivers well-timed electrical pulses to enhance mobility and foster long-term recovery.
To suppress tremors, such as those from Parkinson's disease, scientists equipped a biorobotic arm with artificial muscles, which compensate for the back-and-forth movement of the tremor.
Blood-based biomarker (BBB) tests may represent the best weapon to combat the soaring rates of Alzheimer’s disease (AD) throughout the world. Existing clinically validated tests are currently deployed to facilitate diagnosis, to monitor disease and effectiveness of treatments, to quantify progression, and to determine if a patient is appropriate for treatment or participation in a clinical…
A new blood test, using neurofilament light chainproteins as biomarker, could lead to better diagnosis and management of amyotrophic lateral sclerosis (ALS).
